HTFL Heartflow, Inc.
Heartflow, Inc. (HTFL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $1.6M.
Where they traded
Last open-market purchase: December 16, 2025 , by Lightcap Jeffrey C .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 19,682 | $50.15 | $987.1K | 79,956 −19.8% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 16,766 | $50.75 | $850.9K | 155,183 −9.8% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 7,579 | $50.11 | $379.8K | 171,949 −4.2% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 668 | $50.01 | $33.4K | 179,528 −0.4% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 4,593 | $50.24 | $230.7K | 180,196 −2.5% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 29,714 | $50.06 | $1.5M | 184,789 −13.9% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 3,890 | $50.00 | $194.5K | 321,914 −1.2% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 35,010 | $46.42 | $1.6M | 325,804 −9.7% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 6,640 | $50.03 | $332.2K | 214,503 −3% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 27,540 | $49.69 | $1.4M | 221,143 −11.1% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 5,876 | $50.60 | $297.3K | 248,683 −2.3% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 27,230 | $50.00 | $1.4M | 360,814 −7% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 32,676 | $45.00 | $1.5M | 388,044 −7.8% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 9,219 | $41.23 | $380.1K | 86,459 −9.6% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 15,560 | $39.06 | $607.8K | 420,720 −3.6% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $28.31 | $638.7K | 436,280 −4.9% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 9,219 | $25.72 | $237.1K | 88,731 −9.4% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $27.75 | $626.1K | 435,373 −4.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.